| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/2012 | CA2824805A1 Il-27 antagonists for treating inflammatory diseases |
| 07/19/2012 | CA2824438A1 Use of toll-like receptor agonist for treating cancer |
| 07/19/2012 | CA2824422A1 Use of a vegf antagonist to treat angiogenic eye disorders |
| 07/19/2012 | CA2824347A1 Composition and method for treating cancer |
| 07/19/2012 | CA2824235A1 Novel wnt compositions and therapeutic uses of such compositions |
| 07/19/2012 | CA2824154A1 Method for delivering agents into cells using bacterial toxins |
| 07/19/2012 | CA2824151A1 Antigen surrogates in autoimmune disease |
| 07/19/2012 | CA2814763A1 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 07/18/2012 | EP2476758A1 Method for prediction of therapeutic effect on chronic hepatitis c |
| 07/18/2012 | EP2476701A1 Antimicrobial agents based on hemin derivatives |
| 07/18/2012 | EP2476699A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 07/18/2012 | EP2476698A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 07/18/2012 | EP2476697A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 07/18/2012 | EP2476442A1 Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 07/18/2012 | EP2476440A1 Therapeutic compositions for the treatment of hpv-induced diseases |
| 07/18/2012 | EP2476430A1 Pegylated insulin lispro compounds |
| 07/18/2012 | EP2476429A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units |
| 07/18/2012 | EP2476428A1 Recombinant interferon alpha 2 (IFN alpha 2) mutants |
| 07/18/2012 | EP2476427A2 A method of treating cancer comprising a VEGF-B antagonist |
| 07/18/2012 | EP2476426A1 Treatment and prevention of symptoms of metabolic syndrome |
| 07/18/2012 | EP2476410A1 An analgesic peptide-containing composition for transbuccal administration |
| 07/18/2012 | EP2475779A1 Detecting pax2 for the diagnosis of breast cancer |
| 07/18/2012 | EP2475769A1 Inhibition of histone acetyltransferases by ctk7a and methods thereof |
| 07/18/2012 | EP2475681A1 Plgf-1 in homodimeric form |
| 07/18/2012 | EP2475680A1 Molecules capable of inducing cell death by targeting the mitochondria and applications thereof |
| 07/18/2012 | EP2475427A1 Actriib antagonists and dosing and uses thereof |
| 07/18/2012 | EP2475397A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes |
| 07/18/2012 | EP2475388A1 Use of il-33 antagonists to treat fibrotic disease |
| 07/18/2012 | EP2475381A2 Methods for hematopoietic precursor mobilization |
| 07/18/2012 | EP2475380A1 Composition for treatment of cxcl8-mediated lung inflammation |
| 07/18/2012 | EP2475378A2 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 07/18/2012 | EP2475377A2 Novel bacteriophage and antibacterial composition comprising the same |
| 07/18/2012 | EP2475376A2 Formulations for lysosomal enzymes |
| 07/18/2012 | EP2475375A2 Pi3 kinase inhibitors and uses thereof |
| 07/18/2012 | EP2475373A1 A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 07/18/2012 | EP2399993A9 Hypo-immunogenic streptavidin and use thereof |
| 07/18/2012 | EP2187954B1 Use of alpha-MSH as a therapeutic agent for the treatment of berylliosis |
| 07/18/2012 | EP2132222B1 Anti diabetic protein |
| 07/18/2012 | EP1542701B1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 07/18/2012 | EP1437961B1 Methods of suppressing microglial activation |
| 07/18/2012 | EP1435999B1 Combination of two bioactive regions of pro-opiomelanocortin hormone |
| 07/18/2012 | EP0906577B2 Screening compounds for the ability to alter the production of amyloid-beta peptide |
| 07/18/2012 | CN1946734B Compositions and methods for the systemic treatment of arthritis |
| 07/18/2012 | CN1935260B Human antibodies that bind human tnfalpha |
| 07/18/2012 | CN1774448B Growth factor complexes and modulation of cell migration and growth |
| 07/18/2012 | CN1738636B Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 07/18/2012 | CN1723041B Stable immunogenic product comprising antigenic heterocomplexes |
| 07/18/2012 | CN1468303B Factor vii glycoforms |
| 07/18/2012 | CN1449445B Ev-vegf nucleic acids and polypeptides and methods of use |
| 07/18/2012 | CN102597235A Lung and esophageal cancer related gene ADAMTS18 |
| 07/18/2012 | CN102597225A Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes |
| 07/18/2012 | CN102596992A Fibronectin type III domain based scaffold compositions, methods and uses |
| 07/18/2012 | CN102596990A PLGF-1 in homodimeric form |
| 07/18/2012 | CN102596270A Root canal filler for non-extracted tooth and non-extraction method for regenerating dental tissue |
| 07/18/2012 | CN102596247A Novel proteins |
| 07/18/2012 | CN102596233A Compositions and methods for treating hematologic cancers targeting the SIRPa - CD47 interaction |
| 07/18/2012 | CN102596232A Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 07/18/2012 | CN102596231A Chimeric factor VII molecules |
| 07/18/2012 | CN102596230A Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry |
| 07/18/2012 | CN102596229A Glucagon-like peptide-1 receptor (GLP-1R) agonists for treating autoimmune disorders |
| 07/18/2012 | CN102596228A Neuropeptide-2 receptor (Y-2R) agonists |
| 07/18/2012 | CN102596227A Composition for treatment of CXCL8-mediated lung inflammation |
| 07/18/2012 | CN102596226A Schistosomiasis vaccine compositions and methods of use |
| 07/18/2012 | CN102596225A Use of a neuregulin to treat peripheral nerve injury |
| 07/18/2012 | CN102596224A Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 07/18/2012 | CN102596223A Tumoricidal, bactericidal, or viricidal macrophage activation |
| 07/18/2012 | CN102596222A Dermaseptin B2 used as an inhibitor of the growth of a tumor |
| 07/18/2012 | CN102596221A Immunological targeting of pathological TAU proteins |
| 07/18/2012 | CN102596220A Monophosphorylated lipid A derivatives |
| 07/18/2012 | CN102596219A Novel bacteriophage and antibacterial composition comprising the same |
| 07/18/2012 | CN102596218A New bacitracin antibiotics |
| 07/18/2012 | CN102596217A Modified vasoactive intestinal peptides |
| 07/18/2012 | CN102596216A Therapeutic preparation for rhinitis |
| 07/18/2012 | CN102596215A Method and composition for synchronizing time of insemination |
| 07/18/2012 | CN102596208A Composition to induce specific immune tolerance |
| 07/18/2012 | CN102596201A Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| 07/18/2012 | CN102586437A Application of CCDC72 gene and its expression product in preparing preparation for diagnosing and treating ovarian cancer |
| 07/18/2012 | CN102586375A Application of pistacia vera L. in preparation ACE (Angiotensin Converting Enzyme) inhibitor |
| 07/18/2012 | CN102586323A Method for constructing, expressing and purifying targeted immune fusion protein |
| 07/18/2012 | CN102586313A Preparation method of p75NTR-ED-Fc fusion protein and application of p75NTR-ED-Fc fusion protein in regeneration and functional recovery of injured central nerve |
| 07/18/2012 | CN102586299A Production method and application of recombinant human non-glycosylated erythropoietin and polyethylene glycol modified product thereof |
| 07/18/2012 | CN102586298A Preparation of long-acting human vascular endothelial growth factor 165 |
| 07/18/2012 | CN102586276A 通过操作信使rna前体加工而提供的针对环境毒性的保护 By operating messenger rna precursor processing and provides protection against environmental toxicity |
| 07/18/2012 | CN102586262A Defensin gene of antimicrobial peptide of bemisia tabaci (Gennadius), antimicrobial peptide encoded by defensin gene and preparation method for defensin gene |
| 07/18/2012 | CN102586261A Portunus trituberculatus PtCrustin-2 gene, and coded protein and application thereof |
| 07/18/2012 | CN102586260A PtCrustin-1 gene of Portunus trituberculatus, encoding protein of PtCrustin-1 gene and application of PtCrustin-1 gene |
| 07/18/2012 | CN102586258A Anti-insect peptide of red drum as well as gene cloning method an application thereof |
| 07/18/2012 | CN102586205A Combination of enzyme with enzymatic active site-specific chaperones |
| 07/18/2012 | CN102586129A Oil producing rhodococcus sp.RHA-MLDS having MLDS (Multiple Low Dose Streptozotocin) gene knocked out and purpose of oil producing rhodococcus sp.RHA-MLDS |
| 07/18/2012 | CN102585246A Keratin-copper ions conjugate with simulated superoxide dismutase function |
| 07/18/2012 | CN102585016A Immune fusion protein capable of inhibiting T and B lymphocyte functions and preparation method and application thereof |
| 07/18/2012 | CN102585015A Fusion protein containing glicetin-1 as well as preparation method and application |
| 07/18/2012 | CN102585013A Fusion protein containing omega interferon and method for preparing same |
| 07/18/2012 | CN102585012A Preparation method for grouper alpha interferon derivative and application |
| 07/18/2012 | CN102585011A Preparation method for dog alpha interferon derivative and application |
| 07/18/2012 | CN102584986A Application of neuroglobin to promotion of neurite growth |
| 07/18/2012 | CN102584981A Mutant of interferon alpha and polyethylene glycol derivatives of mutant |
| 07/18/2012 | CN102584980A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 07/18/2012 | CN102584979A Polyethylene glycol (PEG) interferon lambda |
| 07/18/2012 | CN102584977A Porcine defensin pBD2 polypeptide and application thereof in inhibiting porcine pathogenic bacteria |